A detailed history of Wealthcare Advisory Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 34,458 shares of MRK stock, worth $3.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
34,458
Previous 49,240 30.02%
Holding current value
$3.3 Million
Previous $5.59 Million 38.71%
% of portfolio
0.1%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

SELL
$96.31 - $114.76 $1.42 Million - $1.7 Million
-14,782 Reduced 30.02%
34,458 $3.43 Million
Q3 2024

Nov 04, 2024

SELL
$111.15 - $128.97 $307,440 - $356,731
-2,766 Reduced 5.32%
49,240 $5.59 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $44,072 - $47,333
356 Added 0.69%
52,006 $6.44 Million
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $533,700 - $621,880
4,713 Added 10.04%
51,650 $6.82 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $50,590 - $55,055
505 Added 1.09%
46,937 $5.12 Million
Q3 2023

Oct 12, 2023

SELL
$102.95 - $114.33 $274,773 - $305,146
-2,669 Reduced 5.44%
46,432 $4.78 Million
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $888,972 - $968,940
8,185 Added 20.0%
49,101 $5.67 Million
Q1 2023

May 04, 2023

BUY
$102.94 - $114.86 $66,396 - $74,084
645 Added 1.6%
40,916 $4.35 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $225,070 - $288,571
2,574 Added 6.83%
40,271 $4.47 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $600,585 - $674,690
7,105 Added 23.23%
37,697 $3.25 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $151,283 - $171,487
-1,812 Reduced 5.59%
30,592 $2.79 Million
Q1 2022

Apr 15, 2022

BUY
$73.51 - $82.4 $93,798 - $105,142
1,276 Added 4.1%
32,404 $2.66 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $747,375 - $936,183
10,340 Added 49.74%
31,128 $2.39 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $102,502 - $112,726
1,430 Added 7.39%
20,788 $1.56 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $36,209 - $40,051
-515 Reduced 2.59%
19,358 $1.51 Million
Q1 2021

Apr 30, 2021

BUY
$68.86 - $81.11 $135,103 - $159,137
1,962 Added 10.95%
19,873 $1.53 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $73,923 - $82,039
1,030 Added 6.1%
17,911 $1.47 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $10,025 - $11,364
137 Added 0.82%
16,881 $1.4 Million
Q2 2020

Jul 29, 2020

SELL
$70.42 - $80.13 $14,224 - $16,186
-202 Reduced 1.19%
16,744 $1.3 Million
Q1 2020

Apr 29, 2020

BUY
$63.36 - $87.82 $62,853 - $87,117
992 Added 6.22%
16,946 $1.3 Million
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $39,410 - $44,470
508 Added 3.29%
15,954 $1.45 Million
Q3 2019

Oct 17, 2019

BUY
$76.08 - $82.93 $14,531 - $15,839
191 Added 1.25%
15,446 $1.3 Million
Q2 2019

Jul 30, 2019

SELL
$69.84 - $81.59 $85,484 - $99,866
-1,224 Reduced 7.43%
15,255 $1.28 Million
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $8,140 - $9,285
-117 Reduced 0.7%
16,479 $1.37 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $15,396 - $17,867
236 Added 1.44%
16,596 $1.27 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $89,477 - $105,219
-1,551 Reduced 8.66%
16,360 $1.16 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $25,516 - $29,979
502 Added 2.88%
17,911 $1.09 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $80,160 - $93,168
-1,573 Reduced 8.29%
17,409 $948,000
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $35,049 - $41,853
679 Added 3.71%
18,982 $1.07 Million
Q3 2017

Nov 15, 2017

BUY
$58.67 - $63.13 $1.06 Million - $1.14 Million
18,011 Added 6168.15%
18,303 $1.17 Million
Q2 2017

Aug 29, 2017

BUY
N/A
292
292 $19,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.